FDA Adverse Event Injury Summary report: N

INGEVITY+

MDR report key: 18097233 · Received November 8, 2023

Report

Report Number
2124215-2023-62960
Event Type
Injury
Date Received
November 8, 2023
Date of Event
October 19, 2023
Report Date
December 5, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NVN
UDI-DI
00802526604577
PMA / PMN Number
P150012/S083
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. TESTING WAS COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INNER INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, LEAD BODY, AND ELECTRODE TIP FOUND NO ANOMALIES OTHER THAN NORMAL EXPLANT DAMAGE. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS AND DETAILED ANALYSIS DID NOT REVEAL ANY ABNORMALITIES. LABORATORY ANALYSIS DID NOT IDENTIFY ANY LEAD CHARACTERISTICS THAT WOULD HAVE CAUSED OR CONTRIBUTED TO THE REPORTED CLINICAL OBSERVATIONS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS EXPLANTED AND REPLACED DUE TO AN INCREASE IN CAPTURE THRESHOLDS WHICH WAS CONFIRMED TO BE CAUSED BY A MICRO-DISLODGEMENT DURING X-RAY EXAMINATION. THE LEAD WAS RETURNED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS EXPLANTED AND REPLACED DUE TO AN INCREASE IN CAPTURE THRESHOLDS WHICH WAS CONFIRMED TO BE CAUSED BY A MICRO-DISLODGEMENT DURING X-RAY EXAMINATION. THE LEAD WAS RETURNED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
553339 INGEVITY+ IMPLANTABLE LEAD NVN BOSTON SCIENTIFIC CORPORATION 7841 1298408 00802526604577

Patients

Seq Age Sex Outcome Treatment
1 75 YR Female Hospitalization| R